Bio-Rad Laboratories, Inc.
US ˙ NYSE ˙ US0905722072

SecurityBIO / Bio-Rad Laboratories, Inc.
InstitutionHighPoint Advisor Group LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
HighPoint Advisor Group LLC closes position in BIO / Bio-Rad Laboratories, Inc.

On May 14, 2026 - HighPoint Advisor Group LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Bio-Rad Laboratories, Inc. (US:BIO) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 5, 2025 disclosing 749 shares of Bio-Rad Laboratories, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2025-12-31 13F/A-2 BIO RAD LABS INC CL A Common Stock 090572207 0 -100.00 0
2026-02-04 2025-12-31 13F BIO RAD LABS INC CL A Common Stock 090572207 738 -11 -1.47 224 6.19 0.0104
2025-11-05 2025-09-30 13F BIO RAD LABS INC CL A Common Stock 090572207 749 749 210 0.0100
2025-02-12 2024-12-31 13F BIO RAD LABS INC CL A Common Stock 090572207 0 -613 -100.00 0 -100.00
2024-11-04 2024-09-30 13F BIO RAD LABS INC CL A Common Stock 090572207 613 613 226 0.0132
2024-05-14 2024-03-31 13F BIO RAD LABS INC CL A Common Stock 090572207 0 -609 -100.00 0 -100.00
2024-03-26 2023-12-31 13F BIO RAD LABS INC CL A Common Stock 090572207 609 -582 -48.87 208 -65.73 0.0149
2022-08-15 2022-06-30 13F BIO RAD LABS INC CL A Common Stock 090572207 1,191 129 12.15 607 -23.36 0.0664
2021-11-15 2021-09-30 13F BIO RAD LABS INC CL A Common Stock 090572207 1,062 -80 -7.01 792 7.61 0.0776
2021-07-29 2021-06-30 13F BIO RAD LABS INC CL A Common Stock 090572207 1,142 149 15.01 736 23.08 0.0741
2021-04-12 2021-03-31 13F BIO RAD LABS INC CL A Common Stock 090572207 993 158 18.92 598 12.62 0.0692
2021-02-10 2020-12-31 13F BIO RAD LABS INC CL A Common Stock 090572207 835 89 11.93 531 12.98 0.0647
2020-11-06 2020-09-30 13F BIO RAD LABS INC CL A Common Stock 090572207 746 91 13.89 470 57.72 0.0850
2020-08-13 2020-06-30 13F BIO RAD LABS INC CL A Common Stock 090572207 655 121 22.66 298 29.00 0.0637
2020-05-01 2020-03-31 13F/A-2 BIO RAD LABS INC CL A Common Stock 090572207 534 534 231 0.0550
2020-04-27 2020-03-31 13F/A-1 BIO RAD LABS INC CL A Common Stock 090572207 231 -303 1 0.0084
2020-02-13 2019-12-31 13F BIO RAD LABS INC CL A Common Stock 090572207 0 -410 -100.00 0 -100.00
2019-11-12 2019-09-30 13F BIO RAD LABS INC CL A Common Stock 090572207 410 15 3.80 144 17.07 0.0318
2019-08-15 2019-06-30 13F/A-1 BIO RAD LABS INC CL A Common Stock 090572207 395 395 123 0.0288
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.